ライフサイエンスコーパス: disclosure

1 ty, justifiable risk, objectivity, warranted disclosure).

2 , graphical display, and supplemental verbal disclosure).

3 om disclosure, and baseline attitudes toward disclosure.

4 ls, athlete training management, and athlete disclosure.

5 f internal olefin are the highlights of this disclosure.

6 upport and train nurses in relation to error disclosure.

7 uidance from the organisation as barriers to disclosure.

8 errors to patients and perceived barriers to disclosure.

9 ess of potential benefits and limitations of disclosure.

10 fferences in data availability and levels of disclosure.

11 ar of negative consequences was a barrier to disclosure.

12 affective process often resulting in delayed disclosure.

13 hese cohorts in the 14 to 23 years following disclosure.

14 h, although a minority strongly opposed such disclosure.

15 y and beyond, and an emphasis on openness in disclosure.

16 ptual reasons to support a policy of routine disclosure.

17 rom the intrinsic value associated with self-disclosure.

18 strength of the quarantine effect created by disclosure.

19 evel solutions to enable and facilitate IMED disclosure.

20 the welfare effects of mandatory information disclosure.

21 ncial ties became apparent only through self-disclosure.

22 Information sharing was assessed post-disclosure.

23 se of small numbers and risks of statistical disclosure.

24 seeking were completed before and after risk disclosure.

25 alty/patent/intellectual property, and other disclosures.

26 ted overall and within certain categories of disclosures.

27 istration, and eliminating barriers to error disclosures.

28 the minimum US dollar value attributable to disclosures.

29 hers are based increasingly on their digital disclosures.

30 gap between prevalence of GBV (40%) and GBV disclosure (7%), implying an underestimation of GBV that

31 "extremely important" and preferred written disclosure (77%) over other methods.

32 e importance of individualised management of disclosure about a trial following a child's death.

33 ived public stigma predicted lower levels of disclosure about cancer history and experiences.

34 s and 2) situations involving a lack of full disclosure about interventions.

35 enants from leasing an infested rental unit, disclosure also creates a kind of quarantine, partially

36 Early disclosure also reduces parental anxieties concerning di

37 hile many substances were nontoxic, frequent disclosures also included notorious groundwater contamin

38 -perfect ART adherence and mutual HIV status disclosure among all participating couples.

39 Currently, in biology, disclosure and an initial validation are combined in a j

40 nd biospecimens, but current laws offer more disclosure and consent protections for research particip

41 rds HIV and HIV care, thus staff involved in disclosure and linkage activities should be trained to d

42 The disclosure and linkage to care experience is crucial in

43 that cover disclosure of the funding source; disclosure and management of conflicts of interest; mult

44 erences and consent, variant classification, disclosure and management of primary and secondary findi

45 rs influenced Chinese MSM's decisions around disclosure and marriage.

46 s of matches on both company and category of disclosure and matches on company.

47 and materials and activities to support HIV disclosure and parent-led health promotion.

48 Social rules of HIV disclosure and perception of risk depend on the setting

49 Hence, the disclosure and potential manipulation of such pathways m

50 In so doing, we champion disclosure and preregistration, express skepticism about

51 re, emotions involved in disclosure, desired disclosure and recommendations.

52 g and brief intervention to promote safe HIV disclosure and risk reduction in women seeking HIV couns

53 Primary outcomes were self-disclosure and social closeness.

54 cused on recognizing the association between disclosure and surgeons' well-being may help sustain ope

55 orrelation between the presence of a related disclosure and the findings of the studies (p = 0.81), a

56 on existed between the presence of a related disclosure and the results of the studies.

57 Individual panel members provided full disclosure and were judged to be free of any commercial

58 sent requirements, targeted consent's verbal disclosure and written form provide a way to satisfy res

59 ces are risks of research that would require disclosure and written informed consent, but data are la

60 All disclosures and COI management decisions are publicly re

61 dverse event, reported personal effects from disclosure, and baseline attitudes toward disclosure.

62 pproaches to data privacy and the discovery, disclosure, and discussion of sensitive information on p

63 ndatory registry of locations, full chemical disclosure, and, where horizontal drilling is used, pred

64 monitoring of ART, adherence, and diagnosis disclosure are essential to optimize patient care.

65 ate youth adherence, safe sex practices, and disclosure are urgently needed.

66 Prognostic disclosures are associated with more realistic patient e

67 Main Outcomes and Measures: Self-reports of disclosure assessed by 8 items from guidelines and pilot

68 Disclosure at any level was more common in the Amagugu i

69 Surgeons with more negative attitudes about disclosure at baseline reported more anxiety about patie

70 Persons complete disclosures at the start of their participation and are

71 icipants responded to a similar survey about disclosure attitudes.

72 ervention and postintervention surveys about disclosure attitudes.

73 the data products derived from the proposed disclosure avoidance methods, while highlighting critica

74 oth physicians and patients through incident disclosure, but may be ill-prepared to disclose incident

75 Recent research has suggested interest in disclosure, but, to our knowledge, few studies have acco

76 Prognostic disclosure by skilled clinician communicators evokes a r

77 eir LE, but only 17.6% recalled a prognostic disclosure by their physician.

78 bridge the gap between existing alphabetical disclosures by function/CAS number and emerging scientif

79 Early, age appropriate disclosure can better prepare children for future consid

80 However, digital disclosures can come back to haunt, making it challengin

81 ckground disclosure education, ensuring that disclosure coaching is available at all times, and provi

82 lores a new domain within the field of error disclosure, concluding that patients preferred disclosur

83 regard to communication with families, role disclosure, consent discussions, interprofessional confl

84 emerging standard in privacy protection and disclosure control, which is known as differential priva

85 community members in the development of data disclosure (DD) strategies.

86 When faced with decisions about disclosure, decision-makers should be aware not just of

87 Disclosure decisions are also affected by cultural norms

88 A number of recent disclosures describing potent ACC inhibitors have been r

89 the paper; disclosure, emotions involved in disclosure, desired disclosure and recommendations.

90 However, risk disclosure did not affect the decision making among faci

91 Disclosure discrepancies were also analyzed.

92 closure support system, providing background disclosure education, ensuring that disclosure coaching

93 emes that inform the structure of the paper; disclosure, emotions involved in disclosure, desired dis

94 antitative overview relied on voluntary U.S. disclosures evaluated from the FracFocus registry by dif

95 se their self-discovered medical errors, and disclosure expectations and practices have changed accor

96 noted logistical issues that complicated the disclosure experience.

97 -COI Review and Management Panel reviews the disclosures; flags potential conflicts; grades the COI a

98 Patients preferred disclosure for a variety of reasons, most commonly descr

99 asizing the importance of compound structure disclosure for predicting biodegradation products.

100 Authors tended to report more disclosures for research and consulting to ASCO than app

101 te a standard potential conflict of interest disclosure form, which will be available for external re

102 te a standard potential conflict of interest disclosure form, which will be available for external re

103 e also reduces parental anxieties concerning disclosure from an unwitting source.

104 Recent disclosures from clinical trials confirm that it is well

105 The primary outcome was maternal HIV disclosure (full [using the word HIV], partial [using th

106 nd each report included one of three support disclosures: funding from a pharmaceutical company, NIH

107 In closing the "disclosure gap" an understanding of the views of all mem

108 ing about partnership separation, unintended disclosure, gender-based violence, and stigma.

109 Six-month post-disclosure, genetic risk score participants were more li

110 -driven Amagugu intervention to aid parental disclosure has potential for wide-scale implementation a

111 Since 2013, a stream of disclosures has prompted reconsideration of surveillance

112 intraoperative data analysis and transparent disclosure have been advocated to better understand how

113 lf-discovered errors, and strongly preferred disclosure in both scenarios.

114 Patients preferred error disclosure in cases of IMED, describing consistent and s

115 study analyzes patients' preferences around disclosure in cases of IMED.

116 tion to analyze patients' preferences around disclosure in cases of inter-system medical error discov

117 a systematic institutional approach to error disclosure in which the decision to inform the patient s

118 of the authors (22/39, 56%) made no adequate disclosures in their articles.

119 Here we break down priority into two steps: disclosure, in which the discovery is released to the wo

120 Self-disclosure increased over time for the affect dyad (slop

121 The meeting disclosure index was used to tabulate the minimum US dol

122 Cancer disclosure indirectly ameliorated psychological distress

123 ed with year of publication, funding source, disclosure information, or the type of studies pooled.

124 Disclosure-informing advisees of a potential bias-is a p

125 Significant genotype-by-disclosure interaction effects were observed on several

126 psychological distress as mediated by cancer disclosure, internalized reactions to stigma, and social

127 influenced psychological distress via cancer disclosure, internalized shame, and social support avail

128 This increased disclosure is driven by reduced privacy concerns (study

129 sent requirements, targeted consent's verbal disclosure is preferable to waiving consent, provided a

130 Yet how likely is this, when disclosure is so harmful to the individual?

131 nses from women) used 5 of the 8 recommended disclosure items: explained why the event happened (55 o

132 s demonstrating that traditional statistical disclosure limitation techniques often fall short of the

133 We assessed disclosures made in articles related to the off-label us

134 determined, the value amount related to the disclosures made was inadequately reported according to

135 IAL DISCLOSURE(S): Proprietary or commercial disclosure may be found after the references.

136 IAL DISCLOSURE(S): Proprietary or commercial disclosures may be found after the references.

137 ients' surgical outcomes or events following disclosure (odds ratio, 1.54; 95% CI, 1.16-2.06).

138 ion intervention predicted lower interest in disclosure (odds ratio, 2.01; 95% CI, 1.15-3.53; P = .02

139 Disclosure of a genetic risk score for CHD increased inf

140 Given the recent disclosure of a major contribution of the thymus to muri

141 The recent disclosure of a methyl-thiazole series demonstrates that

142 d to interact with them in ways that promote disclosure of actionable health information.

143 ence with AD appears to increase interest in disclosure of AD research results.

144 Interest in disclosure of AD research results.

145 o quantitatively assess surgeons' reports of disclosure of adverse events and aspects of their experi

146 Earlier disclosure of all relevant data would have better inform

147 tion in December 2014 that require mandatory disclosure of allergens in non-pre-packed foods.

148 Disclosure of amyloid imaging results is desired by many

149 they would likely take certain actions after disclosure of another physician's error, ranging from co

150 rticipant introduced themselves and provided disclosure of any potential conflicts of interest.

151 Furthermore, disclosure of APOE nonrisk may have weakened dietary res

152 Legislation mandating disclosure of breast density (BD) information has passed

153 k information led to lower LDL-C levels than disclosure of CHD risk based on conventional risk factor

154 Disclosure of CHD risk estimates that incorporated genet

155 We recommend the DODAC and ODP require full disclosure of COI information and introduce stricter pol

156 quantify and determine the effect of author disclosure of conflict of interest on scientific reporti

157 n Agency's (EPA) current practices regarding disclosure of data underlying regulatory and policy deci

158 n Agency's (EPA) current practices regarding disclosure of data underlying regulatory and policy deci

159 sclosure, concluding that patients preferred disclosure of errors in cases of IMED.

160 ision-making conversations that include full disclosure of evidence involving surgical and nonsurgica

161 Overall, after disclosure of FFR data, management plan based on CA alon

162 Statin efficacy did not differ by disclosure of financial conflict information, use of an

163 ASCO supports thorough and accessible disclosure of financial relationships with companies at

164 ure of industry funding, as compared with no disclosure of funding, led physicians to downgrade the r

165 cle is on the prevalence and determinants of disclosure of GBV to formal authorities, including healt

166 lacking, we need to establish guidelines on disclosure of genetic information and, in the process, w

167 ty leaving nine papers which focussed on the disclosure of genetic information between parent and chi

168 al, legal, and counseling issues surrounding disclosure of genetic information generated by NGS to pa

169 fficult to understand, and the potential for disclosure of genetic information; and a detailed inform

170 Disclosure of genetic risk information about AD and CAD

171 Disclosure of genetic risk information within families i

172 ected or at risk children caused by the (non)disclosure of genetic risk information.

173 to practice and in their attitudes about the disclosure of genomic information of uncertain significa

174 mation is not sufficient, but instead a full disclosure of HF additives is necessary.

175 ent services and reducing stigma surrounding disclosure of HIV results would benefit on-going care of

176 ough a reduction in forced sex and increased disclosure of HIV results.

177 ajor factors influencing adherence were: non-disclosure of HIV status (OR = 17.99, p = 0.014); alcoho

178 that further expand HIV testing and support disclosure of HIV status are needed.

179 sits, poor PMTCT prophylaxis compliance, non-disclosure of HIV status, and non-Sukuma ethnicity.

180 Inappropriate disclosure of human genomes may put the privacy of study

181 t, a large set of control outcomes, and full disclosure of hypotheses tested.

182 ation, there are still good reasons to avoid disclosure of identities.

183 Disclosure of industry funding, as compared with no disc

184 ze-fits-all advice.We determined whether the disclosure of information on fat-mass and obesity-associ

185 nce statement is a comprehensive process for disclosure of interests (DOI) and management of conflict

186 ethods include more stringent policies about disclosure of interests and conflict management; inclusi

187 Board of Trustees developed guidance on the disclosure of interests and management of COIs.

188 We report the first disclosure of IRAK3 degraders in the scientific literatu

189 In preclinical studies, these rules led to disclosure of mutation(s) in more than 10% of these fami

190 erence contrast microscopy to result in full disclosure of nanoscale motions with high accuracy.

191 ed but uninfected will face the challenge of disclosure of parental HIV infection status.

192 authors review the circumstances under which disclosure of patient information about firearms to thir

193 concerns with regard to collection, use, and disclosure of patient information, this article addresse

194 sing conflicts of interest in health care is disclosure of personal financial ties to industry.

195 Disclosure of pleiotropic information did not increase a

196 Systematic disclosure of prevailing intensive care unit norms for m

197 There is increased demand for disclosure of raw data from studies used by the U.S. EPA

198 of 4 key areas pertaining to management and disclosure of risks in clinical trials: identifying and

199 Public disclosure of scientific data used by the government to

200 Findings highlight the potential benefits of disclosure of secondary genetic findings when options ex

201 Disclosure of sex and comparative studies contribute to

202 iscusses liability risks associated with the disclosure of significant research findings for investig

203 Unprotected disclosure of such information might put individual's pr

204 sis can be problematic due to biases in self-disclosure of symptoms, stigma within military populatio

205 rly all participants described compassionate disclosure of test results by ED/UC providers, although

206 After disclosure of the 70-GS test result, the preliminary adv

207 Until our recent disclosure of the beta-lactonization of free aliphatic a

208 pment of novel ATX inhibitors, including the disclosure of the first ATX clinical trial data.

209 Our disclosure of the first enantioselective synthesis of (-

210 an instrument containing 15 items that cover disclosure of the funding source; disclosure and managem

211 X-ray diffractometry allowed the disclosure of the overall molecular conformation in the

212 The disclosure of these synergic cellular mechanisms regulat

213 The recent disclosure of type I 1/2 inhibitors for p38alpha MAPK de

214 Forty-two percent of physicians endorsed disclosure of uncertain genomic findings to patients.

215 (or not sharing) data, combined with public disclosure of which datasets are shared and which are no

216 Moreover, earlier disclosures of an independent discovery of the quinolone

217 This paper explores the impact of disclosures of bias on advisees.

218 r research has focused almost exclusively on disclosures of financial conflicts of interest but littl

219 ts of interest but little is known about how disclosures of other types of biases could impact advise

220 xidizing chemicals, together with occasional disclosures of putative delayed acids and complexing age

221 emically modified apelin peptides and recent disclosures of small molecule agonists and antagonists a

222 oratory experiment, we examine and find that disclosures of specialty bias increase patients' trust a

223 The recent disclosures of two classes of acylborons, potassium acyl

224 mate their LE, those who recalled prognostic disclosure offered more realistic estimates as compared

225 dy examines and contrasts the effect of risk disclosure on risk acceptance and perceived changes in q

226 ith reporting such events, and the effect of disclosure on surgeons.

227 We assessed how providing pro forma disclosures or more descriptive evidence context about t

228 ence of industry on cancer research, greater disclosure, or both.

229 stable partner (p = 0.0008), HIV-serostatus disclosure (p = 0.009), smoking (p < 0.0001), evidence o

230 The non-disclosure patterns suggest shortcomings with authors an

231 rt the calls for development of standardized disclosure policies across medicine.

232 se findings should inform the development of disclosure policies for asymptomatic individuals in AD s

233 cally evaluate the methodology, content, and disclosure policies of CPGs.

234 Over the short term (within 5 years), disclosure policies result in modest increases in cost t

235 use it to evaluate the costs and benefits of disclosure policies to landlords.

236 d surgeons' well-being may help sustain open disclosure policies.

237 shared advisor-advisee decision-making, and disclosure policies.

238 esults by proposing a design for a qualified disclosure policy.

239 individuals by APOE-e4 dose for the genetic disclosure process of the Alzheimer's Prevention Initiat

240 nurses having a greater contribution to the disclosure process, but the provision of support and tra

241 Methods to simplify the disclosure process, improve transparency, and facilitate

242 ts and aspects of their experiences with the disclosure process.

243 ns about how best to structure and implement disclosure processes remain to be answered.

244 eded to determine how best to operationalize disclosure processes so as to maximize prospective benef

245 To sustain open disclosure programs, it is essential to understand how s

246 riants meeting the threshold for recommended disclosure ranges from 3955-12,579 (3.79%-12.06%, 95% CI

247 rom EPA's analysis of the FracFocus Chemical Disclosure Registry 1.0), 8 chemicals (22%) had an avail

248 Financial disclosures reported by 163 authors and presenters who p

249 Importantly, this method also reduces disclosure risk to essentially nil as no record in the s

250 take a selfie (study 1) and induces greater disclosure risks (i.e., people exhibit greater disinhibi

251 However, disclosure risks can sometimes limit the sharing of open

252 c cancer disparities and have relatively low disclosure risks, which we assess by comparing individua

253 FINANCIAL DISCLOSURE(S): Proprietary or commercial disclosure may

254 FINANCIAL DISCLOSURE(S): Proprietary or commercial disclosures may

255 FINANCIAL DISCLOSURE(S): The author(s) have no proprietary or comm

256 FINANCIAL DISCLOSURE(S): The authors have no proprietary or commer

257 FINANCIAL DISCLOSURE(S): The authors have no proprietary or commer

258 FINANCIAL DISCLOSURE(S): The authors have no proprietary or commer

259 FINANCIAL DISCLOSURES(S): The authors have no proprietary or comme

260 Learning about potential limitations of disclosure somewhat tempered interest.

261 The National Bioengineered Food Disclosure Standard requires a mandatory label for genet

262 he date of publication were used to evaluate disclosure statement accuracy, detail the companies prov

263 f the 86 speakers, 66 (76.7%) included a COI disclosure statement and 41 (47.7%) disclosed a COI.

264 tology clinical practice guidelines, compare disclosure statements for accuracy, determine whether ph

265 estion, determined the frequency of adequate disclosure statements, and analyzed characteristics of t

266 r dermatology guidelines and the accuracy of disclosure statements.

267 testosterone in men), age, self-esteem, and disclosure status (whether LGB participants had complete

268 Narrative self-disclosure (storytelling) reduces emotional distress aft

269 Disclosure strategies alone do not provide health profes

270 Such measures as hospitals establishing a disclosure support system, providing background disclosu

271 gen component is demonstrated by a review of disclosures surrounding the efficacy of novel inhibitors

272 This is a much lower rate of adequate disclosure than has been identified in previous studies.

273 xperiences, were more negatively affected by disclosure than others.

274 ses identified a number of barriers to error disclosure that have already been reported in the litera

275 At an interpersonal level, disclosure to a spouse and spousal involvement in treatm

276 We find disclosure to be an effective control policy to curb inf

277 data reported by companies to CDP for public disclosure to build a database of 866 product carbon foo

278 The fear of unwanted disclosure to insurers and the possibility of genetic di

279 Non-disclosure to one's partner, as well as some cultural pr

280 e healthcare team regarding errors and their disclosure to patients is needed.

281 es, continuous self-regulation and proactive disclosure to patients.

282 of an intervention to increase maternal HIV-disclosure to primary school-aged HIV-uninfected childre

283 Median time between disclosure to the proband and counseling of relatives wa

284 essed in the first year(s) after test result disclosure to the proband.

285 Overall concordance between disclosures to ASCO and payments in OP was 16% for compa

286 he advantages of separating these steps into disclosure via a preprint, and validation via a combinat

287 Stakeholders (n = 264) indicated that disclosure was "very important" to "extremely important"

288 Full disclosure was also more common in the Amagugu intervent

289 In adjusted analyses, recall of prognostic disclosure was associated with a 17.2-month decrease (95

290 f evidence statements, and one commentary on disclosure was developed.

291 Interest in disclosure was high among the ADRC participants (55.1% [

292 ers were unable to predict whether a related disclosure was made (p = 0.40).

293 ewers attempted to predict whether a related disclosure was made.

294 Prognostic disclosure was not associated with worse patient-physici

295 Self-disclosure was strongly associated with increased activa

296 he number of variants that might qualify for disclosure, we apply recently published recommendations

297 hods to ensure safety and encourage violence disclosure were used.

298 Expense disclosures were more frequently reported in OP than to

299 Patient preferences about disclosure when physicians discover another provider's e

300 One contentious policy is disclosure, whereby landlords are obligated to notify po